Related Experiment Videos
Phase-shift markers in Bordetella: alterations in envelope proteins.
The Journal of Infectious Diseases
|April 1, 1981
Summary
Bordetella pertussis envelope proteins differ between virulent phase I and avirulent phase IV strains. These protein differences are also observed in related Bordetella species, impacting vaccine development and diagnostics.
Area of Science:
- Microbiology
- Immunology
- Bacteriology
Background:
- Bordetella pertussis causes whooping cough, a significant public health concern.
- Pertussis vaccines target bacterial envelope components, necessitating detailed characterization of these antigens.
- Understanding antigenic variation across Bordetella species is crucial for effective vaccine design and disease control.
Purpose of the Study:
- To compare the protein profiles of envelope preparations from different phases and species of Bordetella.
- To identify key envelope proteins that distinguish virulent from avirulent strains.
- To investigate the conservation of these proteins across Bordetella parapertussis and Bordetella bronchiseptica.
Main Methods:
- Analysis of Bordetella envelope proteins using SDS-PAGE.
- Comparison of protein profiles between phase I, phase IV, and C-mode cells.
- Comparative proteomic analysis of Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica.
Main Results:
- Phase I Bordetella pertussis strains possess at least 10 major envelope proteins.
- Four major proteins are significantly reduced or absent in phase IV strains and C-mode cells.
- Bordetella parapertussis and Bordetella bronchiseptica exhibit similar but distinct envelope protein profiles compared to B. pertussis.
Conclusions:
- Significant differences in envelope protein composition exist between virulent and avirulent Bordetella strains.
- These variations suggest potential targets for novel diagnostics and therapeutics.
- Comparative analysis highlights species-specific protein variations within the Bordetella genus.